News
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last year's strong market rally. Both finished 2024 slightly in the red. They're
Is AbbVie Stock a Buy Now?
AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, the biopharmaceuticals giant delivered 6% sales growth and $2.12 in
Why Zoetis Stock Took Another Tumble Today
One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (NYSE: ZTS) shares again tumbled. As of late-session trading on Friday, they were down
The Ultimate Healthcare Stock to Buy With $500 Right Now
Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare stocks as a group are barely in positive territory.
However, I remain
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business. And
DexCom (DXCM) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
DexCom (NASDAQ: DXCM)Q4 2024 Earnings CallFeb 13, 2025, 4:30 p.m. ET
Operator
Source Fool.com
DexCom: Revenue Up, EPS Misses Mark
DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
Healthcare in vitro diagnostics company QuidelOrtho (NASDAQ: QDEL) attracted the right kind of attention from investors after posting its latest quarterly earnings report on Thursday. A rather
Why Zoetis Stock Was Falling Today
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short in its fourth quarter.
Though it topped estimates on the top and
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q4 2024 Earnings CallFeb 13, 2025, 8:30 a.m. ET
Operator
Source Fool.com
Zoetis Earnings Top Analysts' Forecasts
Zoetis (NYSE:ZTS), the leader in animal health solutions, released its fourth quarter results for 2024 on Feb. 13. The company reported an adjusted earnings per share (EPS) of $1.40, which exceeded
Are Investors Being Too Paranoid About Pfizer Stock?
Investing in a top healthcare company whose share price has been tanking in recent years could present a huge opportunity for investors, especially when that company has been bolstering its growth
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Most companies don't survive for decades, much less pay regular dividends for that long. However, some rare corporations can pull it off. These are the kinds of stocks long-term investors will often
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
I'm about to get a big cash infusion in my portfolio. Last year, private equity giant Blackstone agreed to buy one of my holdings, Retail Opportunity Investments Corp., in an all-cash deal. That
Biogen (BIIB) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q4 2024 Earnings CallFeb 12, 2025, 8:30 a.m. ET
Operator
Source Fool.com
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
Vertex: Strong Sales, Stronger Pipeline
Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report.
Vertex reported solid fourth-quarter numbers throughout its business. While the company's earnings
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q4 2024 Earnings CallFeb 10, 2025, 4:30 p.m. ET
Operator
Source Fool.com
Vertex's Revenue Surges but EPS Slips
Vertex Pharmaceuticals(NASDAQ:VRTX), known for its innovative treatments, reported its fourth-quarter earnings on Feb. 10. The company's revenue increased significantly to $2.91 billion, which was
Why Illumina Stock Got Mashed on Monday
On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition
Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader
Better High-Yield Dividend Stock: Pfizer vs. Merck
Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical industry. At recent prices, you can buy shares of Merck (NYSE: MRK) that
3 Fabulous Dividend Stocks to Buy in February
February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three Motley Fool contributors believe they have identified fabulous dividend stocks
2 Growth Stocks to Buy Hand Over Fist in February
Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in other industries -- even in healthcare, a sector some investors might